These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10533730)

  • 21. Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
    Mohr P; Makki A; Breitbart E; Schadendorf D
    Melanoma Res; 1998 Apr; 8(2):166-9. PubMed ID: 9610871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients.
    Rixe O; Borel C; Paraiso D; Benhammouda A; Petit T; Antoine E; Bizzari JP; Auclerc G; Soubrane C; Weil M
    Melanoma Res; 1995 Dec; 5(6):419-24. PubMed ID: 8589616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
    Seeber A; Binder M; Steiner A; Wolff K; Pehamberger H
    Eur J Cancer; 1998 Dec; 34(13):2129-31. PubMed ID: 10070323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
    Mornex F; Thomas L; Mohr P; Hauschild A; Delaunay MM; Lesimple T; Tilgen W; Bui BN; Guillot B; Ulrich J; Bourdin S; Mousseau M; Cupissol D; Bonneterre ME; De Gislain C; Bensadoun RJ; Clavel M
    Melanoma Res; 2003 Feb; 13(1):97-103. PubMed ID: 12569292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation.
    Gruss C; Geissler A; Schalke B; Landthaler M; Stolz W
    Melanoma Res; 2002 Aug; 12(4):403-4. PubMed ID: 12170192
    [No Abstract]   [Full Text] [Related]  

  • 26. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
    Di Giacomo AM; Ascierto PA; Pilla L; Santinami M; Ferrucci PF; Giannarelli D; Marasco A; Rivoltini L; Simeone E; Nicoletti SV; Fonsatti E; Annesi D; Queirolo P; Testori A; Ridolfi R; Parmiani G; Maio M
    Lancet Oncol; 2012 Sep; 13(9):879-86. PubMed ID: 22894884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated limb perfusion with fotemustine after chemosensitization with dacarbazine in melanoma.
    Pontes L; Lopes M; Ribeiro M; Santos JG; Azevedo MC
    Melanoma Res; 1997 Oct; 7(5):417-9. PubMed ID: 9429225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
    Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
    Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fotemustine plus dacarbazine for malignant melanoma.
    Avril MF; Bonneterre J; Cupissol D; Grob JJ; Kalis B; Fumoleau P; Kerbrat P; Israel L; Fargeot P; Lambert D
    Eur J Cancer; 1992; 28A(11):1807-11. PubMed ID: 1389514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapy.
    Margolin KA; Di Giacomo AM; Maio M
    Semin Oncol; 2010 Oct; 37(5):468-72. PubMed ID: 21074062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.
    Jacquillat C; Khayat D; Banzet P; Weil M; Fumoleau P; Avril MF; Namer M; Bonneterre J; Kerbrat P; Bonerandi JJ
    Cancer; 1990 Nov; 66(9):1873-8. PubMed ID: 2224783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
    Guida M; Tommasi S; Strippoli S; Natalicchio MI; De Summa S; Pinto R; Cramarossa A; Albano A; Pisconti S; Aieta M; Ridolfi R; Azzariti A; Guida G; Lorusso V; Colucci G
    BMC Cancer; 2018 May; 18(1):552. PubMed ID: 29747595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of fotemustine in patients with metastatic malignant melanoma.
    Falkson CI; Falkson G; Falkson HC
    Invest New Drugs; 1994; 12(3):251-4. PubMed ID: 7896545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological toxicity during metastatic melanoma treatment with fotemustine.
    Khalil Z; Pageot N; Carlander B; Guillot B
    Melanoma Res; 2005 Dec; 15(6):563-4. PubMed ID: 16314745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma.
    Semb KA; Aamdal S; Bohmann T; Lucas C; Gerard B
    Melanoma Res; 1998 Dec; 8(6):565-72. PubMed ID: 9918419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.